FDA Approved: TERCONAZOLE — Original Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Cosette Pharmaceuticals' original application for terconazole (generic) under an ANDA, for the treatment of vulvovaginal candidiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• Terconazole (generic) (Terconazole)

Snippet

ORIG AP for TERCONAZOLE (TERCONAZOLE)